Types of Giant Cell ArteritisCauses (Risk Factors and Triggers)SymptomsDiagnostic TestsNon-Pharmacological TreatmentsDrug TreatmentsDietary Molecular SupplementsRegenerative and Stem Cell–Related DrugsSurgical ProceduresPrevention StrategiesWhen to See a DoctorWhat to Eat and What to AvoidFrequently Asked QuestionsGiant cell arteritis is a serious condition in which the walls of medium- and large-sized arteries (the blood vessels carrying blood away from the heart) become inflamed (swollen, red, and painful). This inflammation is caused by the body’s own immune system attacking the artery wall, forming clusters of immune cells—including “giant cells”—that damage the blood vessel lining. Giant cell arteritis most often affects the temporal arteries (located on the sides of the head) but can involve other major vessels, such as the branches of the aorta (the main artery from the heart) NCBIMayo Clinic Proceedings. Because it commonly involves the temples, it is also called temporal arteritis Mayo ClinicMayo Clinic Proceedings. Giant cell arteritis occurs almost exclusively in people over 50 years old, with highest risk between ages 70 and 80 Arthritis FoundationPMC.Giant cell arteritis (GCA) is a disease where the body’s immune system attacks the walls of medium- and large-sized arteries, most often the branches of the external carotid artery in the head. When these arteries become inflamed, they thicken and can narrow, reducing blood flow. Left untreated, GCA can cause severe complications such as sudden vision loss, stroke, and aortic aneurysm. It primarily affects people over 50 years old, with headaches, scalp tenderness, jaw pain when chewing, and fatigue being common signs. Mayo ClinicWikipediaLeft untreated, the swelling and damage inside arteries can block blood flow, leading to serious problems such as sudden loss of vision (when arteries to the eye are affected) or even stroke if arteries to the brain are involved. Early recognition and treatment—usually with strong anti-inflammatory medicines—are critical to prevent permanent harm Mayo ClinicNIAMS.Types of Giant Cell ArteritisDoctors recognize several varieties of giant cell arteritis based on which arteries are affected and the pattern of disease:Cranial (Temporal) GCA: Involvement mainly of the branches of the external carotid artery, especially the temporal artery on the side of the head.Large-Vessel GCA: Affecting larger arteries such as the aorta (the body’s main artery) and its major branches in the chest and abdomen.Occult GCA: When typical cranial symptoms (like headache) are absent, but blood tests and biopsy still show giant cell arteritis.Overlap with Polymyalgia Rheumatica (PMR): About half of people with GCA also have PMR, a condition marked by muscle pain and stiffness in the shoulders and hips PMCMayo Clinic Proceedings.Causes (Risk Factors and Triggers)The exact “cause” of giant cell arteritis is not known. However, research has identified many factors that make it more likely by triggering or worsening the inflammation:Age over 50 years – virtually all patients are older than 50; risk rises sharply after 70 PMCArthritis Foundation.Female sex – women are two to three times more likely than men to develop GCA Arthritis Foundation.Caucasian ethnicity – highest rates occur in people of Northern European descent Arthritis Foundation.HLA-DRB1*04 genetic variant – a specific immune-system gene strongly linked to GCA susceptibility PMC+1PMC+1.Family history of GCA or PMR – relatives of patients have a slightly increased risk PMC.Seasonal variation – some studies show more new cases in spring and winter Mayo Clinic News Network.Smoking – tobacco use may worsen blood vessel inflammation Mayo Clinic News Network.Low vitamin D levels – vitamin D helps regulate immune responses; low levels may increase risk Mayo Clinic News Network.Varicella-Zoster Virus (VZV) infection – viral particles found in many inflamed arteries suggest past chickenpox reactivation may trigger GCA Mayo Clinic ProceedingsScienceDirect.Epstein-Barr Virus (EBV) – another common virus theorized to trigger inflammation in susceptible people Mayo Clinic News Network.Cytomegalovirus (CMV) – similarly studied as a possible trigger for artery inflammation Mayo Clinic News Network.Parvovirus B19 – detection of this virus in some patients’ artery samples Mayo Clinic News Network.High levels of interleukin-6 (IL-6) – a key immune signaling protein that drives inflammation in GCA Johns Hopkins Vasculitis CenterUpToDate.Elevated interferon-gamma (IFN-γ) – another immune messenger found in artery walls Johns Hopkins Vasculitis Center.Other autoimmune diseases – such as rheumatoid arthritis or lupus, indicating a general tendency toward immune overactivity Mayo Clinic News Network.Atherosclerosis – fatty “hardening” of arteries may alter vessel walls and make them more reactive to inflammation Mayo Clinic News Network.Environmental toxins – pollutants may trigger abnormal immune responses in vessel linings Mayo Clinic News Network.Chronic stress – persistent stress can dysregulate the immune system, possibly precipitating GCA Verywell Mind.Polymyalgia rheumatica association – having PMR increases GCA risk and vice versa; many patients experience both conditions Mayo Clinic ProceedingsArthritis Foundation.Inadequate immune regulation with age – as people grow older, their immune “brakes” weaken, making attacks on healthy vessels more likely PMCAHA Journals.SymptomsInflamed arteries in giant cell arteritis cause a mix of local (near the artery) and general (whole-body) problems. Common symptoms include:New, severe headaches – often throbbing, usually on one side near the temple Mayo ClinicCleveland Clinic.Scalp tenderness – pain when touching or combing hair over the temples Mayo ClinicNIAMS.Jaw claudication – pain or cramping in the jaw when chewing (like muscle tiredness) Mayo ClinicPubMed.Vision changes – blurred vision, double vision (diplopia), or sudden loss of vision in one eye Mayo ClinicCleveland Clinic.Fever – mild to moderate increase in body temperature (above 100.4°F or 38°C) PubMed.Fatigue – overall feeling of tiredness and low energy PubMed.Weight loss – unintentional loss of appetite and body weight PubMed.Night sweats – excessive sweating during sleep PubMed.Muscle aches and stiffness – especially in shoulders and hips, often overlapping with PMR Mayo Clinic ProceedingsNIAMS.Weakness – feeling of muscle weakness, especially in the arms or legs PubMed.Loss of appetite – eating less due to general malaise or mouth pain PubMed.Depression or low mood – feeling down or uninterested in normal activities Verywell Mind.Tenderness over large arteries – such as the carotid (neck) or subclavian (under the collarbone) arteries NIAMS.Difficulty opening mouth – due to jaw muscle pain or weakness Verywell Health.Arm or leg claudication – pain in the arms or legs with use, if large vessels to the limbs are involved Mayo Clinic Proceedings.Diagnostic TestsTo confirm giant cell arteritis, doctors combine hands-on checks, lab tests, tissue analysis, electrical measurements, and imaging studies. Below are the 20 key tests grouped by type:Physical Exam TestsVital signs – checking temperature (fever) and heart rate (fast rate may signal inflammation) NIAMS.Blood pressure in both arms – differences >10 mm Hg may suggest artery narrowing on one side NIAMS.Pulse examination – feeling pulses in the wrists and ankles to detect weak or missing pulses from blocked vessels NIAMS.Manual Tests (by Hand)Temporal artery palpation – pressing the temple to feel for hardness, thickening, or a pulseless artery Mayo Clinic.Scalp sensitivity test – gently stroking scalp hair to check for tenderness Mayo Clinic.Jaw-clench provocation – asking the patient to chew or clench jaw to reproduce pain PubMed.Shoulder range-of-motion test – lifting arms to assess stiffness from PMR overlap NIAMS.Cranial nerve exam – checking eye movements and facial sensation to spot nerve involvement NIAMS.Laboratory & Pathological TestsErythrocyte Sedimentation Rate (ESR) – measures how fast red blood cells settle in a tube; high rates (often >50 mm/hour) show inflammation Johns Hopkins Vasculitis CenterAmerican Academy of Ophthalmology.C-Reactive Protein (CRP) – blood marker that rises quickly with inflammation; elevated in nearly all GCA cases Johns Hopkins Vasculitis CenterAmerican Academy of Ophthalmology.Complete Blood Count (CBC) – checks for anemia (low red cells) and high white cells (infection/inflammation) Johns Hopkins Vasculitis Center.Platelet count – often high in active GCA, reflecting inflammation Johns Hopkins Vasculitis Center.Liver function tests (LFTs) – mild increases in enzymes can occur with systemic inflammation Johns Hopkins Vasculitis Center.Interleukin-6 (IL-6) level – research test measuring this key inflammatory protein Johns Hopkins Vasculitis Center.Temporal artery biopsy – gold standard: a small piece of the temple artery is removed under local anesthesia and examined under a microscope for giant cells and damage to layers of the vessel Mayo ClinicOxford Academic.Electrodiagnostic TestsVisual Evoked Potentials (VEP) – measures electrical signals from the eye to the brain, detecting slowed nerve conduction if optic nerves are affected Medscape.Electroretinography (ERG) – records electrical responses of the retina (back of the eye) to light, showing reduced signals if blood flow is poor Medscape.Somatosensory Evoked Potentials (SSEP) – measures nerve signals from skin to brain, used if scalp or facial sensory nerves are suspected to be inflamed Medscape.Imaging TestsTemporal artery ultrasound – a non-invasive scan showing a “halo sign” (dark ring) around the artery where the wall is swollen PubMedMayo Clinic.Magnetic Resonance Angiography (MRA) or CT Angiography – 3D pictures of the arteries showing narrowing, blockage, or aneurysms in large vessels MedscapePubMed.Positron Emission Tomography (PET) scan – uses radioactive tracer to find active inflammation in large arteries throughout the body PubMed.Non-Pharmacological TreatmentsNote: Specific studies of non-drug therapies in GCA are limited. The following measures draw on general anti-inflammatory and vascular-health strategies that may support overall well-being in GCA patients.Regular Gentle ExerciseModerate activities such as walking or swimming help improve blood flow and reduce inflammation by promoting healthy vessel function and lowering stress hormones.Stress Management and RelaxationTechniques like deep-breathing, meditation, or guided imagery can calm the immune system, potentially reducing inflammation signals that drive arterial swelling.Adequate Sleep HygieneAiming for 7–8 hours of quality sleep each night supports immune balance, as lack of sleep raises inflammatory markers like C-reactive protein.Scalp and Head WarmthUsing a warm (not hot) compress on the temples can relieve tenderness and improve local blood flow, easing headache discomfort.Massage TherapyGentle neck and shoulder massage can loosen tight muscles and improve circulation, offering modest pain relief around the head and neck.Occupational TherapyTherapists teach energy-conserving techniques and modifications to daily activities that limit strain on inflamed arteries and reduce fatigue.HydrotherapyAlternating warm and cool showers may stimulate vessel flexibility and relieve muscle tension without harsh side effects.Yoga and Tai ChiThese mind-body practices combine gentle movement with breath control, supporting both vascular health and stress reduction.Support Groups and CounselingSharing experiences with others facing GCA can decrease anxiety, which may otherwise worsen inflammation through stress pathways.Smoking CessationStopping smoking removes a potent trigger of vascular inflammation and improves response to therapy by preserving vessel function.Sun ProtectionWearing wide-brimmed hats and sunscreen guards the delicate temporal artery region from UV damage, which can exacerbate inflammation.Anti-Inflammatory Diet PlanningWorking with a nutritionist to focus on whole foods helps reduce systemic inflammation and supports overall health (see Dietary Supplements and Foods section).Cold Pack TherapyApplying a cool pack to the jaw during chewing may ease jaw-claudication pain by temporarily constricting local blood vessels.Mindfulness-Based Stress Reduction (MBSR)Structured programs in mindfulness have been shown to lower inflammatory markers in chronic diseases and may benefit GCA patients.Pacing and Activity ManagementBreaking tasks into smaller steps and resting between activities prevents overexertion, which can spike inflammatory mediators.Home Safety AssessmentOccupational therapists evaluate the home to reduce fall risk in patients on long-term steroids, which can weaken bones.Adaptive Eating UtensilsUsing ergonomically designed cutlery can reduce jaw strain in those experiencing jaw pain during meals.Gentle Neck StretchesDaily stretching exercises improve regional circulation and may relieve tension that contributes to headache.Heat and Cold Contrast TherapyAlternating moist heating pads with cool compresses can soothe aching arteries and tense muscles without drugs.Patient Education on Symptom MonitoringTeaching patients to recognize warning signs—new headache patterns, vision changes, or jaw pain—promotes early medical care and faster management.Drug TreatmentsAll medication dosages should be tailored by a physician based on patient age, weight, kidney/liver function, and risk factors.PrednisoneClass: GlucocorticoidDosage: 40–60 mg orally once daily (initial)Time: Morning, to mimic natural cortisol rhythmPurpose: Rapidly reduce arterial inflammation and prevent vision lossMechanism: Binds to intracellular receptors, suppressing genes that drive immune activationSide Effects: Weight gain, mood swings, osteoporosis, high blood sugar MedscapeMethylprednisoloneClass: Glucocorticoid (IV form)Dosage: 1 g IV daily for 3 days (severe vision symptoms)Time: Inpatient setting, early morning infusionPurpose: Achieve rapid control in acute visual lossMechanism: Potent anti-inflammatory action reduces immune cell infiltrationSide Effects: Immunosuppression, mood disturbance, electrolyte imbalance MedscapeMethotrexateClass: Antimetabolite, steroid-sparing agentDosage: 15–20 mg subcutaneously or orally once weeklyTime: Consistent day each week; folic acid on other daysPurpose: Lower steroid dose needed by controlling inflammationMechanism: Inhibits dihydrofolate reductase, reducing proliferation of inflammatory cellsSide Effects: Mouth sores, liver enzyme elevation, lung toxicity Mayo Clinic ProceedingsAzathioprineClass: Purine analog immunosuppressantDosage: 1.5–2 mg/kg/day orallyTime: Divided into morning and evening dosesPurpose: Steroid-sparing and long-term inflammation controlMechanism: Stops DNA synthesis in white blood cellsSide Effects: Bone marrow suppression, liver toxicity, increased infection riskTocilizumabClass: IL-6 receptor antagonist (biologic)Dosage: 162 mg subcutaneously weeklyTime: Same day each week, at homePurpose: Induce and maintain remission, reduce relapse on steroid taperMechanism: Blocks interleukin-6 signaling, a key driver of GCA inflammationSide Effects: Elevated liver enzymes, lipid changes, infusion reactions Massachusetts General HospitalInfliximabClass: TNF-α inhibitorDosage: 3–5 mg/kg IV at weeks 0, 2, 6, then every 8 weeksTime: Infusion centerPurpose: Used off-label as steroid-sparing in refractory casesMechanism: Binds TNF-α, preventing its action on vessel wallsSide Effects: Infection risk, infusion reactions, possible demyelinating diseaseAdalimumabClass: TNF-α inhibitorDosage: 40 mg subcutaneously every other weekTime: Bi-weekly at homePurpose: Alternative to infliximab for patients intolerant to IV therapyMechanism: Neutralizes TNF-α to reduce vessel inflammationSide Effects: Injection‐site reactions, increased infection riskCyclophosphamideClass: Alkylating agentDosage: 500–1000 mg/m² IV every 3–4 weeksTime: Infusion center, with hydrationPurpose: Reserved for life‐ or vision‐threatening GCA resistant to other therapiesMechanism: Crosslinks DNA, leading to immune cell deathSide Effects: Bladder toxicity, bone marrow suppression, nauseaLeflunomideClass: Pyrimidine synthesis inhibitorDosage: 20 mg orally once dailyTime: MorningPurpose: Steroid‐sparing in patients intolerant to methotrexateMechanism: Inhibits dihydroorotate dehydrogenase, reducing lymphocyte proliferationSide Effects: Liver enzyme elevation, alopecia, gastrointestinal upsetAspirin (Low-Dose)Class: Antiplatelet agentDosage: 75–100 mg orally once dailyTime: MorningPurpose: Reduce risk of cranial ischemic events (e.g., stroke, vision loss)Mechanism: Irreversibly blocks COX-1 in platelets, reducing clot formationSide Effects: Gastrointestinal irritation, bleeding risk PubMedDietary Molecular Supplements(These have anti-inflammatory or vascular-protective properties but are adjunctive, not replacements for medical treatment.)Omega-3 Fish Oil (1–2 g/day)Contains EPA/DHA that help resolve inflammation by producing anti-inflammatory eicosanoids.Curcumin (Turmeric Extract) (500 mg twice daily)Blocks NF-κB pathways, reducing production of inflammatory cytokines.Vitamin D₃ (2000 IU/day)Modulates immune response, with deficiency linked to higher autoimmune activity.Magnesium (300 mg/day)Supports blood vessel relaxation and may lower CRP levels, an inflammation marker.Resveratrol (100 mg/day)Activates SIRT1, which dampens immune cell activation and oxidative stress.Ginger Extract (250 mg three times daily)Suppresses prostaglandin and leukotriene synthesis, easing pain and swelling.Green Tea Polyphenols (EGCG) (400 mg/day)Inhibits COX-2 and cytokine release, offering vascular protection.Coenzyme Q10 (100 mg/day)Improves mitochondrial health in vessel walls, reducing oxidative damage.N-Acetylcysteine (600 mg twice daily)Boosts glutathione levels to counter oxidative stress in inflamed arteries.Probiotics (Lactobacillus and Bifidobacterium strains) (10⁹ CFU/day)Promote gut barrier integrity and reduce systemic inflammation via the gut-immune axis.Regenerative and Stem Cell–Related Drugs(Experimental or off-label; consult specialized centers.)Autologous Mesenchymal Stem Cell InfusionUses patient’s own stem cells to modulate immune response and promote vessel repair.Tocilizumab + Mesenchymal Stem CellsCombines IL-6 blockade with cell therapy to enhance immunoregulation in refractory GCA.Rituximab (375 mg/m² IV weekly ×4)Depletes B cells that present antigens to T cells, potentially resetting autoimmunity.Ustekinumab (90 mg subcutaneously every 8 weeks)Targets IL-12/23, reducing Th1 and Th17 pathways implicated in granulomatous inflammation.Abatacept (10 mg/kg IV day 1, then every 4 weeks)Blocks CD28-mediated T-cell activation, dampening the autoimmune attack on vessel walls.Autologous Regulatory T-Cell TherapyExpands and reinfuses patient’s own Tregs to restore immune tolerance toward arterial antigens.Surgical ProceduresTemporal Artery BiopsyRemoves a small segment of the temple artery under local anesthesia to confirm GCA by finding giant cells and inflammation.Aortic Aneurysm RepairOpen or endovascular surgery to replace or reinforce a weakened portion of the aorta that has dilated from chronic inflammation.Carotid EndarterectomyRemoves plaque or inflammatory narrowing in the carotid artery to restore blood flow and reduce stroke risk.Arterial Bypass GraftingBypasses a damaged or narrowed artery segment with a vessel graft to maintain adequate circulation to critical organs.Angioplasty and StentingThreads a balloon and stent into narrowed large vessels (e.g., subclavian artery) to widen the passage and prevent ischemia.Prevention StrategiesEarly Screening in At-Risk IndividualsAdults over 50 with new headaches or jaw pain should have ESR/CRP tests to catch GCA early.Maintain Healthy Blood PressureHigh blood pressure damages vessel walls, increasing risk of complications in GCA.Control Blood SugarDiabetes worsens vascular inflammation; good glycemic control reduces arterial damage.Quit SmokingTobacco amplifies immune attacks on vessels and impairs healing.Balanced Anti-Inflammatory DietFocus on whole grains, lean proteins, fruits, and vegetables to lower systemic inflammation.Regular ExercisePromotes vascular health and lowers chronic inflammation markers like CRP.Annual Flu and Pneumococcal VaccinesPrevent infections that can trigger GCA flare-ups.Bone Health MonitoringLong-term steroids weaken bones; DEXA scans every 1–2 years help guide calcium/vitamin D supplementation.Stress Reduction RoutinesChronic stress can fuel inflammation; mindfulness and relaxation techniques help maintain remission.Avoid Prolonged Sun ExposureUV light can worsen skin and vessel inflammation; use sun protection when outdoors.When to See a DoctorSeek immediate medical attention if you experience:New or sudden severe headache, especially around the temples.Scalp tenderness when combing hair or touching the head.Jaw pain or tightness while chewing or talking.Vision changes, such as blurred vision, double vision, or sudden vision loss.Arm or leg claudication, with pain when using the limbs.Unexplained fever, night sweats, or significant weight loss.New cough or difficulty breathing, which may signal large-vessel involvement.Prompt evaluation—including blood tests (ESR, CRP), imaging (ultrasound, MRI), and biopsy—can prevent irreversible complications. Mayo ClinicWhat to Eat and What to AvoidEat: Olive oil — Avoid: Trans fats (found in fried and processed foods)Eat: Fatty fish (salmon, mackerel) — Avoid: Processed meats (sausage, bacon)Eat: Leafy greens (spinach, kale) — Avoid: Refined sugars (soda, candy)Eat: Berries (blueberries, strawberries) — Avoid: Excessive alcoholEat: Nuts and seeds (almonds, flaxseeds) — Avoid: High-salt snacks (chips, pretzels)Eat: Whole grains (oats, brown rice) — Avoid: White bread and pastriesEat: Yogurt with live cultures — Avoid: High-fat dairy (whole milk, cream)Eat: Turmeric-seasoned dishes — Avoid: Artificial additives and preservativesEat: Garlic and onions — Avoid: Deep-fried foodsEat: Green tea — Avoid: Drinks high in caffeine and sugarThis “eat vs. avoid” plan emphasizes anti-inflammatory, nutrient-dense foods that support vascular health while minimizing foods that can spike inflammation and oxidative stress.Frequently Asked QuestionsWhat causes giant cell arteritis?The exact cause is unknown, but it involves an abnormal immune response—with T cells and macrophages attacking artery walls—possibly triggered by genetics or infections ScienceDirect.Who is at risk for GCA?People over age 50—especially women of Northern European descent—are most at risk. Having polymyalgia rheumatica also raises risk.Can GCA be cured?There is no cure, but early treatment with steroids and biologics often brings lasting remission and prevents complications.How long do I need steroids?Typically 12–18 months of tapering, guided by symptoms and inflammatory markers, though some patients require longer courses.What are the main side effects of prednisone?Weight gain, mood swings, high blood sugar, increased infection risk, osteoporosis, and muscle weakness.Is temporal artery biopsy always needed?Biopsy is the gold standard but may be skipped if imaging (ultrasound/MRI) plus clinical signs strongly suggest GCA and immediate treatment is essential.Can GCA affect blood vessels outside the head?Yes—large vessels such as the aorta and its branches can be involved, leading to aneurysm or vessel narrowing elsewhere.What laboratory tests monitor GCA?Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) track inflammation. Rising levels may signal relapse.Is GCA hereditary?Family history slightly increases risk, but it is not directly inherited. Multiple genes likely contribute to susceptibility.Can I stop treatment if I feel better?No—symptoms may subside before vessels fully heal. Always follow your doctor’s tapering plan and monitoring schedule.Are there natural remedies that work?Supplements like omega-3, curcumin, and vitamin D may support treatment but should never replace prescribed medications.How often should I have follow-up visits?Initially every 1–3 months, then spacing out based on stability. Regular monitoring is key to avoid flare-ups.Can I get a vaccine while on immunosuppressants?Inactivated vaccines (flu, pneumococcal) are recommended; live vaccines should generally be avoided or timed carefully.What if I develop vision changes?Treat GCA as a medical emergency. Immediate IV steroids can preserve vision in many cases.What lifestyle changes help manage GCA?Eat an anti-inflammatory diet, stay active, avoid smoking, manage stress, and practice good sleep hygiene to support overall treatment.Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.The article is written by Team RxHarun and reviewed by the Rx Editorial Board MembersLast Updated: August 04, 2025.PDF Document For This Disease ConditionsEye Diseases [rxharun.com] lucentis-epar-product-information-Eye Diseases [rxharun.com] jesc110 – Eye Diseases [rxharun.com] 9789240082458-eng [Eye Diseases (rxharun.com)] d1e1894daab433a1-9ed1066742d1-p67-Watson-et-al-v3 [Eye Diseases (rxharun.com)] PIIS0161642024000125 [Eye Diseases (rxharun.com)] OCT_in_Retinal_Diseases_Cozzi_EN [Eye Diseases (rxharun.com)]Eye76. Corneal Disorders [Eye Diseases (rxharun.com)] N.R. Galloway [Eye Diseases (rxharun.com)] OM – Definition & Classification [Eye Diseases (rxharun.com)] wcms_892937 [Eye Diseases (rxharun.com)] Diabetes1 [Eye Diseases (rxharun.com)] specific_eye_conditions [Eye Diseases (rxharun.com)] CEHJ95_Ocular-Surface-Disorders-1 [Eye Diseases (rxharun.com)] 17677-68019-2-PB [Eye Diseases (rxharun.com)] conditions [Eye Diseases (rxharun.com)] primary-care-approach-to-eye-conditions [Eye Diseases (rxharun.com)] Symptoms-Related-to-Eye-Diseases-and-Conditions-2 [Eye Diseases (rxharun.com)] Eye-Disease-Enc-eye-clopedia. [Eye Diseases (rxharun.com)] MCH-Conf-Mar-2019-6-Sandra-Staffieri-Clinical-Update-Paediatric-Eye-Disease [Eye Diseases (rxharun.com)]Adult-Hospital-Chapter-18-Eye-Disorders-with-supporting-NEMLC-report-and-reviews-2020-4-Version-1.0-30-September-2024 [Eye Diseases (rxharun.com)] hod0615i [Eye Diseases (rxharun.com)] The Cornea and Corneal Disease [Eye Diseases (rxharun.com)] August 2018 Feature [Eye Diseases (rxharun.com)] bpj54-pages8-21 [Eye Diseases (rxharun.com)] KaplanArianeDecember5CommonEye [Eye Diseases (rxharun.com)] ophthalmology-iv-handout-2016-17 [Eye Diseases (rxharun.com)] Common-Eye-Diseases-Ceu [Eye Diseases (rxharun.com)] externalEYE-DISEASE [Eye Diseases (rxharun.com)] EJHM_Volume 77_Issue 1_Pages 4754-4759 [Eye Diseases (rxharun.com)] Systemic [Eye Diseases (rxharun.com)] 9789241516570-eng [Eye Diseases (rxharun.com)] gp-handbook-common-eye-condition-management [Eye Diseases (rxharun.com)] Eye Care for FLW- Common Eye related conditions and Service Delivery Framework [Eye Diseases (rxharun.com)] hod0618i [Eye Diseases (rxharun.com)] Eye-Disorders-Guideline [Eye Diseases (rxharun.com)] kevt103 [Eye Diseases (rxharun.com)] Common Eye Diseases and their Management [Eye Diseases (rxharun.com)] eyediseases-book-aecp_Eng [Eye Diseases (rxharun.com)]Referenceshttps://www.aao.org/eye-health/https://www.nei.nih.gov/https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseaseshttps://www.cdc.gov/vision-health/about-eye-disorders/index.htmlhttps://www.oxfordfamilyvisioncare.com/blog/different-types-of-eye-diseases/https://www.aoa.org/healthy-eyes/eye-and-vision-conditionshttps://www.fda.gov/media/124641/downloadhttps://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairmenthttps://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseaseshttps://www.ncbi.nlm.nih.gov/books/NBK22174/https://pubmed.ncbi.nlm.nih.gov/34201117/https://www.amazon.com/Eye-Book-Complete-Disorders-Hopkins/dp/1421440008https://www.amazon.com/Eye-Diseases-Disorders-Complete-Guide/dp/1922227323https://link.springer.com/book/10.1007/978-1-4471-3521-0https://www.ncbi.nlm.nih.gov/books/NBK582134/https://www.ncbi.nlm.nih.gov/books/NBK22174/https://www.ncbi.nlm.nih.gov/mesh?https://academic.oup.com/ije/article/29/5/951/821890https://en.wikipedia.org/wiki/Category:Eye_diseaseshttps://en.wikipedia.org/wiki/Eye_diseasehttps://medlineplus.gov/eyediseases.htmlhttps://eye.hms.harvard.edu/ormihttps://www.cera.org.au/conditions/https://jamanetwork.com/journals/jama/fullarticle/2760387https://www.sciencedirect.com/topics/nursing-and-health-professions/eye-diseasehttps://biotechhealthcare.com/common-eye-disorders-and-diseases/https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&contentid=p00499https://pubmed.ncbi.nlm.nih.gov/35715505/https://www.sciencedirect.com/science/article/pii/S1934590918302315https://europe.ophthalmologytimes.com/view/bringing-biologics-to-eye-health-regenerative-medicine-for-inflammatory-disordershttps://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239https://www.nibib.nih.gov/https://www.nei.nih.gov/https://oxfordtreatment.com/https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/https://www.nccih.nih.gov/healthhttps://catalog.ninds.nih.gov/https://www.aarda.org/diseaselist/https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheetshttps://www.nibib.nih.gov/https://www.nia.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.nimh.nih.gov/health/topicshttps://www.nichd.nih.gov/https://www.niehs.nih.gov/https://www.nimhd.nih.gov/https://www.nhlbi.nih.gov/health-topicshttps://obssr.od.nih.gov/.https://www.nichd.nih.gov/health/topicshttps://rarediseases.info.nih.gov/diseaseshttps://beta.rarediseases.info.nih.gov/diseaseshttps://orwh.od.nih.gov/ SaveSavedRemoved 0 PreviousGhost Cell Glaucoma NextGiant Fornix Syndrome (GFS) Related ArticlesAdded to wishlistRemoved from wishlist 0 Axial osteosclerosisAdded to wishlistRemoved from wishlist 1 Phlebectatic Osteohypoplastic AngiodysplasiaAdded to wishlistRemoved from wishlist 1 Angio Osteohypotrophic SyndromeAdded to wishlistRemoved from wishlist 0 Osteitis